menu search

helius medical technologies, inc. to release third quarter 2023 financial results on november 9, 2023; announces extended cash runway into q2 2024

-- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient T...

November 2, 2023, 5:05 pm

helius medical technologies, inc. receives letter of intent from the québec ministry of health and social services to purchase 30 pons® devices

— PoNS® devices to be provided to a least five sites in five separate administrative regions within Québec —— Government-funded initiative wil...

October 12, 2023, 11:05 am

University of montreal’s school of rehabilitation to purchase ten pons® devices for research study on stroke recovery

— The study will evaluate the optimal time to use PoNS Therapy™ during a patient’s stroke recovery journey — NEWTOWN, Pa., Sept. 20, 2023 (GLO...

September 20, 2023, 11:05 am

helius medical technologies to present at the 2023 interdisciplinary association of functional neuroscience and rehabilitation conference

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation techno...

September 13, 2023, 7:05 am

Why is helius medical technologies (hsdt) stock up 47% today?

helius Medical Technologies (NASDAQ: HSDT ) stock is rising higher on Tuesday as investors react to th...

September 5, 2023, 8:32 am

helius medical technologies, inc. (hsdt) q2 2023 earnings call transcript

helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 ...

August 10, 2023, 8:44 pm

helius medical technologies, inc. (hsdt) reports q2 loss, tops revenue estimates

helius Medical Technologies, Inc. (HSDT) came out with a quarterly loss of $0.06 per share versus the Z...

August 10, 2023, 7:46 pm

helius medical technologies, inc. announces participation of montefiore medical center in its pons® therapeutic experience program

Sixth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects�...

August 7, 2023, 11:05 am

helius medical technologies, inc. expands stroke trial at the medical university of south carolina

— Number of subjects increased from 12 to 60 —— Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve non-invasive...

July 27, 2023, 11:05 am

helius medical technologies announces dmepos accreditation for pons

— Critical initial step toward US reimbursement — NEWTOWN, Pa., June 20, 2023 (GLOBE NEWSWIRE) — helius<...

June 20, 2023, 11:05 am

helius medical technologies to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest

NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- helius Medical Technologies, Inc. (Nasdaq:HSDT) (“...

June 14, 2023, 4:05 pm

helius medical technologies to present at ld micro invitational xiii 2023

Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - helius Medical Technologies, Inc. (NASDAQ: HSD...

May 25, 2023, 7:05 am

helius medical technologies to spotlight expanded authorizations for its pons device at 2023 american academy of neurology annual meeting, booth 1685

MS, Stroke and mmTBI Cover Broader Set of Indications Across North American Markets NEWTOWN, Pa., April 17, 2023 (GLOBE NEWSWIRE) — ...

April 17, 2023, 11:05 am

helius medical technologies, inc. (hsdt) q4 2022 earnings call transcript

helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM...

March 10, 2023, 6:19 pm

helius medical technologies, inc. to release fourth quarter and full year 2022 financial results on march 9, 2023

NEWTOWN, Pa., March 06, 2023 (GLOBE NEWSWIRE) -- helius Medical Technologies, Inc. (NASDAQ: HSDT) (“<...

March 6, 2023, 7:30 am

helius medical technologies, inc. announces preliminary results for the fourth quarter and full year 2022

— Q4 2022 revenue projected to range from $275,000 to $285,000 —— Full year 2022 revenue projected to range from $780,000 to $790,000 —— Una...

January 23, 2023, 12:05 pm

helius extends its patient therapy access program (ptap), bringing the benefits of its pons® device to more people with multiple sclerosis

PTAP Lowers the Cost of PoNS Therapy™ for Qualified Americans NEWTOWN, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) — ...

January 5, 2023, 12:41 pm

5 winning stocks backed by the overlooked rising p/e trick

Want to try an out-of-the-box approach? Tap AMC Entertainment (AMC), Live Nation Entertainment (LYV), CuriosityStream (CURI), ...

November 21, 2022, 9:02 am

helius medical technologies, inc. (hsdt) q3 2022 earnings call transcript

helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q3 2022 Earnings Conference Call November 14, 2022 8:3...

November 14, 2022, 10:45 am

helius medical technologies: a net-net meme stock in the making

A curious $14.5m microcap that $100m in value has transacted through in just 15 trading sessions. A recent equity raise increased cash position by $16...

August 23, 2022, 8:03 am


Search within

Pages Search Results: